Search
Release Society (CRS) honors outstanding individuals who have significantly advanced the field of drug delivery. This year, Prof. Claus-Michael Lehr has been awarded the CRS Distinguished Service Award [...] Professor at Saarland University as well…
Sören Klein
year later in Prof. Martin Empting's “Anti-Infective Drug Discovery” research group. His research focuses on the synthesis and optimization of new drug candidates for the novel anti-tumor and diabetes target
Read moreAna Matos
on optimizing the manufacturing techniques of topical and transdermal drug delivery systems. She has now joined the Department of Drug Delivery Across Biological Barriers from Prof. Claus-Michael Lehr, as
Read moreDr Walid A. M. Elgaher
focuses on the application of modern drug design approaches tackling un(der)exploited therapeutic targets and the use of biophysical and computational techniques for drug discovery and optimization.
Read moreadopt a target-based strategy focused on a diverse portfolio of biologically relevant, underexplored drug targets, including enzymes, transporters, and regulators within bacterial pathogens. These targets [...] microbiota. We employ a range…
Read moreNews
RSS
historically played a crucial role in drug discovery due to their bioactivity-rich scaffolds, which serve as valuable templates for therapeutic agents. However, their use in drug development has dwindled, primarily
Read moreDr Jörg Haupenthal
is a senior scientist (biologist) in the research department Drug Design and Optimisation at HIPS. After researching novel anti-cancer drugs for several years, he started focusing on the development of
Read moreBIOBARRIERS 2021
Location: Online
conference focused on drug delivery in the context of infection research. The interfaces of the outer epithelia (skin, GI, and lungs) as either target tissue or barrier for non-invasive drug delivery are the